The application of estrogen receptor-1 mutations' detection through circulating tumor dna in breast cancer

by Binliang Liu, Yalan Yang, Zongbi Yi, Xiuwen Guan, Fei Ma
Published 2017-01-01

Clinical spectrum and prognostic value of TP53 mutations in circulating tumor DNA from breast cancer patients in China

by Zongbi Yi, Fei Ma, Guohua Rong, Yanfang Guan, Chunxiao Li, Binghe Xu
Published 2020-06-01

Everolimus in hormone receptor-positive metastatic breast cancer: PIK3CA mutation H1047R was a potential efficacy biomarker in a retrospective study

by Zongbi Yi, Fei Ma, Binliang Liu, Xiuwen Guan, Lixi Li, Chunxiao Li, Haili Qian, Binghe Xu
Published 2019-05-01

Genome-wide chromosomal instability by cell-free DNA sequencing predicts survival in patients with metastatic breast cancer

by Hongnan Mo, Xiaobing Wang, Fei Ma, Ziliang Qian, Xiaoying Sun, Zongbi Yi, Xiuwen Guan, Lixi Li, Binliang Liu, Binghe Xu
Published 2020-10-01

Longitudinal HER2 amplification tracked in circulating tumor DNA for therapeutic effect monitoring and prognostic evaluation in patients with breast cancer

by Xiuwen Guan, Binliang Liu, Yunyun Niu, Xin Dong, Xia Zhu, Chunxiao Li, Lixi Li, Zongbi Yi, Xiaoying Sun, Hongyan Chen, Sijia Lu, Fei Ma
Published 2020-02-01

Landscape of somatic mutations in different subtypes of advanced breast cancer with circulating tumor DNA analysis

by Zongbi Yi, Fei Ma, Chunxiao Li, Rongrong Chen, Lifang Yuan, Xiaoying Sun, Xiuwen Guan, Lixi Li, Binliang Liu, Yanfang Guan, Haili Qian, Binghe Xu
Published 2017-07-01

Gut Microbiota Profiling in Patients With HER2-Negative Metastatic Breast Cancer Receiving Metronomic Chemotherapy of Capecitabine Compared to Those Under Conventional Dosage

by Xiuwen Guan, Fei Ma, Fei Ma, Xiaoying Sun, Chunxiao Li, Lixi Li, Fang Liang, Shaochuan Li, Zongbi Yi, Binliang Liu, Binghe Xu, Binghe Xu
Published 2020-07-01

The association between early-onset cardiac events caused by neoadjuvant or adjuvant chemotherapy in triple-negative breast cancer patients and some novel autophagy-related polymor...

by Binliang Liu, Tao An, Meiying Li, Zongbi Yi, Chunxiao Li, Xiaoying Sun, Xiuwen Guan, Lixi Li, Yanfeng Wang, Yuhui Zhang, Binghe Xu, Fei Ma, Yixin Zeng
Published 2018-12-01

The molecular tumor burden index as a response evaluation criterion in breast cancer

by Zongbi Yi, Fei Ma, Guohua Rong, Binliang Liu, Yanfang Guan, Jin Li, Xiaoying Sun, Wenna Wang, Xiuwen Guan, Hongnan Mo, Jiani Wang, Haili Qian, Binghe Xu
Published 2021-07-01

Safety and efficacy of sirolimus combined with endocrine therapy in patients with advanced hormone receptor-positive breast cancer and the exploration of biomarkers

by Zongbi Yi, Binliang Liu, Xiaoying Sun, Guohua Rong, Wenna Wang, Hui Li, Xiuwen Guan, Lixi Li, Jingtong Zhai, Chunxiao Li, Haili Qian, Fei Ma, Binghe Xu
Published 2020-08-01

Epithelial-Mesenchymal-Transition-Like Circulating Tumor Cell-Associated White Blood Cell Clusters as a Prognostic Biomarker in HR-Positive/HER2-Negative Metastatic Breast Cancer

by Xiuwen Guan, Chunxiao Li, Yiqun Li, Jiani Wang, Zongbi Yi, Binliang Liu, Hongyan Chen, Jiasen Xu, Haili Qian, Binghe Xu, Binghe Xu, Fei Ma, Fei Ma
Published 2021-06-01

Development and Validation of a New Clinical Prediction Model of Catheter-Related Thrombosis Based on Vascular Ultrasound Diagnosis in Cancer Patients

by Binliang Liu, Junying Xie, Xiaoying Sun, Yanfeng Wang, Zhong Yuan, Xiyu Liu, Zhou Huang, Jiani Wang, Hongnan Mo, Zongbi Yi, Xiuwen Guan, Lixi Li, Wenna Wang, Hong Li, Fei Ma, Yixin Zeng, Yixin Zeng
Published 2020-10-01

Profile, treatment patterns, and influencing factors of anthracycline use in breast cancer patients in China: A nation‐wide multicenter study

by Fengzhu Guo, Zongbi Yi, Wenna Wang, Yiqun Han, Pei Yu, Su Zhang, Quchang Ouyang, Min Yan, Xiaojia Wang, Xichun Hu, Zefei Jiang, Tao Huang, Zhongsheng Tong, Shusen Wang, Yongmei Yin, Hui Li, Runxiang Yang, Huawei Yang, Yuee Teng, Tao Sun, Li Cai, Hongyuan Li, Xi Chen, Jianjun He, Xinlan Liu, Shune Yang, Jinhu Fan, Youlin Qiao, Jiayu Wang, Binghe Xu
Published 2021-10-01